Fibrobiologics Inc (FBLG)

$0.61 0.00 (-0.21%)
Market Cap 25.61M
Revenue (ttm) 0.00
Net Income (ttm) -11.16M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 9.38
Volume 290,200
Avg Vol 518,990
Day's Range N/A - N/A
Shares Out 41.89M
Stochastic %K 56%
Beta -0.74
Analysts Strong Sell
Price Target $10.25

Company Profile

FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.

Industry: Biotechnology
Sector: Healthcare
Phone: 281-651-5150
Address:
455 East Medical Center Boulevard, Suite 300, Houston, United States
FibonacciPro
FibonacciPro Aug. 27 at 4:49 AM
$FBLG sideways action, needs catalyst for direction.
0 · Reply
elopapa
elopapa Aug. 26 at 12:10 AM
$FBLG In the 90s I'd call this a fibroblast
0 · Reply
CTBRD
CTBRD Aug. 25 at 6:17 PM
$FBLG big jump incoming
0 · Reply
R151515
R151515 Aug. 25 at 6:07 PM
$OPEN $FBLG $IXHL
0 · Reply
R151515
R151515 Aug. 25 at 6:06 PM
$IXHL $FBLG
0 · Reply
R151515
R151515 Aug. 25 at 5:37 PM
$FBLG analyst price target $13, crazy discount right now if that holds to be true
0 · Reply
MrTicker
MrTicker Aug. 25 at 2:19 PM
$FBLG starting to break out.. keep an eye on it
0 · Reply
derider58
derider58 Aug. 25 at 1:27 PM
$FBLG
0 · Reply
elopapa
elopapa Aug. 23 at 11:43 AM
$FBLG I just got in on this one. I'm a long term/holding investor. I like the research they are doing and hoping for another 10,000,000$ in market cap injection and 40 cents upward mobility in stock price to stay compliant. Praying this happens sooner rather than later.
1 · Reply
Dex021
Dex021 Aug. 22 at 8:58 PM
$FBLG trying to buy at 0.55
0 · Reply
Latest News on FBLG
FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Jul 31, 2025, 4:30 PM EDT - 26 days ago

FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

FibroBiologics Files Patent for Methods of Generating Multipotent Cells from Donor Tissue for Clinical Applications

Jul 28, 2025, 8:30 AM EDT - 4 weeks ago

FibroBiologics Files Patent for Methods of Generating Multipotent Cells from Donor Tissue for Clinical Applications

FibroBiologics to Present at the Advanced Wound Care Summit USA

Jul 11, 2025, 8:30 AM EDT - 6 weeks ago

FibroBiologics to Present at the Advanced Wound Care Summit USA

FibroBiologics Confirms Ability to Manufacture CybroCell™ for Degenerative Disc Disease and Cartilage Repair Programs from Existing CYWC628 Master Cell Bank

Jul 9, 2025, 8:30 AM EDT - 6 weeks ago

FibroBiologics Confirms Ability to Manufacture CybroCell™ for Degenerative Disc Disease and Cartilage Repair Programs from Existing CYWC628 Master Cell Bank

FibroBiologics' to Present at Exclusive Live Investor Webinar and Q&A Session on July 10

Jul 7, 2025, 4:35 PM EDT - 7 weeks ago

FibroBiologics' to Present at Exclusive Live Investor Webinar and Q&A Session on July 10

FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing

Jun 16, 2025, 4:35 PM EDT - 2 months ago

FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing

FibroBiologics to Present at the BIO International Convention 2025

Jun 16, 2025, 9:50 AM EDT - 2 months ago

FibroBiologics to Present at the BIO International Convention 2025

FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer

Jun 9, 2025, 8:30 AM EDT - 2 months ago

FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer

FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting

May 16, 2025, 8:30 AM EDT - 3 months ago

FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting

FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 14, 2025, 4:30 PM EDT - 3 months ago

FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update

FibroBiologics Presenting at the ThymUS 2025 Meeting

Apr 29, 2025, 9:15 AM EDT - 4 months ago

FibroBiologics Presenting at the ThymUS 2025 Meeting

FibroBiologics Presents at the ThymUS 2025 Meeting

Apr 29, 2025, 9:15 AM EDT - 4 months ago

FibroBiologics Presents at the ThymUS 2025 Meeting

FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean

Apr 11, 2025, 8:30 AM EDT - 4 months ago

FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean

FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics

Apr 8, 2025, 8:30 AM EDT - 5 months ago

FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics

FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair

Apr 2, 2025, 8:30 AM EDT - 5 months ago

FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair

FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 31, 2025, 4:25 PM EDT - 5 months ago

FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update

FibroBiologics Announces 2025 Annual Meeting of Stockholders

Mar 27, 2025, 8:30 AM EDT - 5 months ago

FibroBiologics Announces 2025 Annual Meeting of Stockholders

FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting

Mar 21, 2025, 8:30 AM EDT - 5 months ago

FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting

FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics

Mar 4, 2025, 8:30 AM EST - 6 months ago

FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics

FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic

Feb 27, 2025, 8:30 AM EST - 6 months ago

FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic

FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates

Feb 5, 2025, 9:15 AM EST - 7 months ago

FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

Dec 30, 2024, 4:30 PM EST - 8 months ago

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing

Dec 30, 2024, 2:12 PM EST - 8 months ago

D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing

FibroBiologics Announces $25 Million Financing

Dec 23, 2024, 7:55 AM EST - 8 months ago

FibroBiologics Announces $25 Million Financing

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly

Nov 19, 2024, 9:15 AM EST - 10 months ago

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics

Nov 14, 2024, 9:15 AM EST - 10 months ago

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics

FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 12, 2024, 4:20 PM EST - 10 months ago

FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology

Oct 29, 2024, 9:15 AM EDT - 10 months ago

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology

FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024

Oct 28, 2024, 9:31 AM EDT - 10 months ago

FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

Oct 18, 2024, 8:30 AM EDT - 11 months ago

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office

Oct 16, 2024, 9:15 AM EDT - 11 months ago

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit

Oct 11, 2024, 9:31 AM EDT - 11 months ago

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa

Sep 30, 2024, 9:31 AM EDT - 11 months ago

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa

FibroBiologics Engages Southern Star Research as CRO in Australia

Sep 19, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Engages Southern Star Research as CRO in Australia

FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology

Sep 12, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology

FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 6, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology

Aug 20, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology

FibroBiologics Files 2024 Second Quarter Report

Aug 7, 2024, 6:52 PM EDT - 1 year ago

FibroBiologics Files 2024 Second Quarter Report

FibroBiologics to Present at JonesTrading Healthcare Summit 2024

Jul 15, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at JonesTrading Healthcare Summit 2024

FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology

Jun 25, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology

FibroBiologics Set to Join Russell 2000® Index

Jun 13, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Set to Join Russell 2000® Index

FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024

Jun 6, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024

FibroBiologics Announces 2024 Annual Meeting of Stockholders

May 15, 2024, 4:30 PM EDT - 1 year ago

FibroBiologics Announces 2024 Annual Meeting of Stockholders

FibroBiologics Files 2024 First Quarter Report

May 14, 2024, 5:24 PM EDT - 1 year ago

FibroBiologics Files 2024 First Quarter Report

FibroBiologics to Present at the BIO International Convention 2024

May 7, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at the BIO International Convention 2024

FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office

Apr 11, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office

FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

Apr 4, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus

Mar 28, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus

FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment

Mar 19, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment

FibroBiologics to Present at Advanced Wound Care Summit USA

Mar 13, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at Advanced Wound Care Summit USA

FibonacciPro
FibonacciPro Aug. 27 at 4:49 AM
$FBLG sideways action, needs catalyst for direction.
0 · Reply
elopapa
elopapa Aug. 26 at 12:10 AM
$FBLG In the 90s I'd call this a fibroblast
0 · Reply
CTBRD
CTBRD Aug. 25 at 6:17 PM
$FBLG big jump incoming
0 · Reply
R151515
R151515 Aug. 25 at 6:07 PM
$OPEN $FBLG $IXHL
0 · Reply
R151515
R151515 Aug. 25 at 6:06 PM
$IXHL $FBLG
0 · Reply
R151515
R151515 Aug. 25 at 5:37 PM
$FBLG analyst price target $13, crazy discount right now if that holds to be true
0 · Reply
MrTicker
MrTicker Aug. 25 at 2:19 PM
$FBLG starting to break out.. keep an eye on it
0 · Reply
derider58
derider58 Aug. 25 at 1:27 PM
$FBLG
0 · Reply
elopapa
elopapa Aug. 23 at 11:43 AM
$FBLG I just got in on this one. I'm a long term/holding investor. I like the research they are doing and hoping for another 10,000,000$ in market cap injection and 40 cents upward mobility in stock price to stay compliant. Praying this happens sooner rather than later.
1 · Reply
Dex021
Dex021 Aug. 22 at 8:58 PM
$FBLG trying to buy at 0.55
0 · Reply
RagePrince
RagePrince Aug. 22 at 6:58 PM
$FBLG
0 · Reply
AnUnwiseInvestor
AnUnwiseInvestor Aug. 22 at 3:54 PM
$FBLG .70 or more please
0 · Reply
B10E
B10E Aug. 22 at 3:11 PM
$FBLG Lets go!
0 · Reply
derider58
derider58 Aug. 21 at 1:44 PM
$FBLG
1 · Reply
MisoHawny
MisoHawny Aug. 20 at 7:28 PM
$FBLG https://theopinionpages.com/2025/08/the-fibroblast-revolution-a-future-beyond-aging/
0 · Reply
Statwell7
Statwell7 Aug. 18 at 7:29 PM
$FBLG it's alive!
0 · Reply
WeAllFallDown
WeAllFallDown Aug. 14 at 10:19 AM
$FBLG Tremendous opportunity but a long haul on this one to go
0 · Reply
Love_To_Learn
Love_To_Learn Aug. 12 at 11:44 PM
$FBLG me off this 0.6*
0 · Reply
Ruuuudy
Ruuuudy Aug. 8 at 7:52 PM
16 dollar price target.. 58 cent stock. do the math $FBLG $SPY
1 · Reply
Cookem_up09
Cookem_up09 Aug. 6 at 1:30 PM
$FBLG trials should be coming later this year.
0 · Reply
Cookem_up09
Cookem_up09 Aug. 6 at 2:17 AM
$FBLG you guys have no idea what’s to come.
2 · Reply
Peace2026
Peace2026 Aug. 5 at 6:57 PM
$FBLG https://www.gurufocus.com/news/3034258/fibrobiologics-fblg-sees-price-target-raised-by-hc-wainwright-fblg-stock-news
0 · Reply